PFKP and glioblastoma: After detecting the expression of PFKP in human glioblastoma and investigating a possible regulation mechanism, Lee et al[50] drew a conclusion that decreased degradation of PFKP due to phosphorylation correlated with clinical aggressiveness of glioblastoma.